Tyburski J G, Wilson R F, Warsow K M, McCreadie S
Department of Surgery, Detroit Receiving Hospital, Mich 48201, USA.
Arch Surg. 1998 Dec;133(12):1289-96. doi: 10.1001/archsurg.133.12.1289.
To determine whether a combination of ciprofloxacin hydrochloride and metronidazole hydrochloride would be as effective or more effective than a combination of gentamicin sulfate and metronidazole hydrochloride for preventing infection in patients with penetrating abdominal trauma, to evaluate the factors associated with increased risk of infection, and to determine the serum peak and trough levels of gentamicin with the dosage regimen of 2.5 mg/kg every 12 hours.
Randomized double-blind study.
Level I trauma center.
Eighty-four patients with penetrating intra-abdominal injuries (gunshot wound, 69; stab wound, 15) thought to require laparotomy.
The patients were randomized during treatment in the emergency department to be given a combination of ciprofloxacin hydrochloride, 400 mg every 12 hours, and metronidazole hydrochloride, 500 mg every 6 hours, or a combination of gentamicin sulfate, 2.5 mg/kg every 12 hours, and metronidazole hydrochloride, 500 mg every 6 hours.
Of 68 patients with intra-abdominal injuries who could be observed for at least 48 hours after laparotomy, posttraumatic infections developed in 12 (18%), and nosocomial infections developed in 6 (9%). The incidence of posttraumatic infections in patients who were given gentamicin and metronidazole (5/33 [15%]) was not significantly lower than the incidence in patients who were given ciprofloxacin and metronidazole (7 of 35 [20%]; P=.75). The presence of any infection increased the mean+/-SD length of hospital stay from 8.7+/-3.5 days to 23.3+/-10.9 days and increased the mean+/-SD hospital charges from $24 507+/-$9860 to $104920+/-$49083 (P<.001). Univariate analysis showed the factors most significantly associated with infection were as follows: (1) the use of blood transfusions (P<.001), (2) the penetrating abdominal trauma index of 35 or more (P<.002), (3) injury to the colon requiring a colostomy (P=.004), and (4) a trauma score of less than 12 (P<.02). Multivariate analysis showed the only significant factor was the receipt of blood transfusions (F=10.165; P<.005).
Ciprofloxacin and gentamicin, each in combination with metronidazole, were equivalent in their ability to prevent infections after penetrating abdominal trauma; other factors, especially the receipt of blood transfusions, had much more effect on the incidence of infection. Infection greatly increases the length of hospital stay and hospital charges. The use of an increased dosing regimen of 2.5 mg/kg every 12 hours of gentamicin sulfate was effective at obtaining a therapeutic peak serum concentration.
确定盐酸环丙沙星与盐酸甲硝唑联合用药预防腹部穿透伤患者感染的效果是否与硫酸庆大霉素和盐酸甲硝唑联合用药相同或更有效,评估与感染风险增加相关的因素,并确定每12小时2.5mg/kg剂量方案下庆大霉素的血清峰浓度和谷浓度。
随机双盲研究。
一级创伤中心。
84例腹部穿透伤患者(枪伤69例;刺伤15例),均认为需要进行剖腹手术。
患者在急诊科治疗期间被随机分组,分别给予每12小时400mg盐酸环丙沙星与每6小时500mg盐酸甲硝唑联合用药,或每12小时2.5mg/kg硫酸庆大霉素与每6小时500mg盐酸甲硝唑联合用药。
68例腹部损伤患者在剖腹手术后至少可观察48小时,其中12例(18%)发生创伤后感染,6例(9%)发生医院感染。接受庆大霉素和甲硝唑治疗的患者创伤后感染发生率(5/33[15%])并不显著低于接受环丙沙星和甲硝唑治疗的患者(35例中的7例[20%];P=0.75)。发生任何感染都会使平均住院时间(均值±标准差)从8.7±3.5天增加到23.3±10.9天,并使平均住院费用(均值±标准差)从24507±9860美元增加到104920±49083美元(P<0.001)。单因素分析显示与感染最显著相关的因素如下:(1)输血的使用(P<0.001),(2)腹部穿透伤指数为35或更高(P<0.002),(3)结肠损伤需要进行结肠造口术(P=0.004),以及(4)创伤评分低于12分(P<0.02)。多因素分析显示唯一显著的因素是输血情况(F=10.165;P<0.005)。
环丙沙星和庆大霉素分别与甲硝唑联合使用,在预防腹部穿透伤后感染的能力上相当;其他因素,尤其是输血情况,对感染发生率的影响更大。感染会大大增加住院时间和住院费用。每12小时2.5mg/kg的硫酸庆大霉素增加剂量方案可有效获得治疗性血清峰浓度。